Integrated analyses of single-cell atlases reveal age, gender, and smoking status associations with cell type-specific expression of mediators of SARS-CoV-2 viral entry and highlights inflammatory programs in putative target cells

Christoph Muus(Broad Institute), Malte D. Luecken(Helmholtz Zentrum München), Gökcen Eraslan(Broad Institute), Avinash Waghray(Massachusetts General Hospital), Graham Heimberg(Broad Institute), Lisa Sikkema(Helmholtz Zentrum München), Yoshihiko Kobayashi(Duke University), Eeshit Dhaval Vaishnav(Broad Institute), Ayshwarya Subramanian(Broad Institute), Christopher Smilie(Broad Institute), Karthik A. Jagadeesh(Broad Institute), Thu Elizabeth Duong(University of California San Diego), Evgenij Fiškin(Broad Institute), Elena Torlai Triglia(Broad Institute), Meshal Ansari(Helmholtz Zentrum München), Peiwen Cai(Icahn School of Medicine at Mount Sinai), Brian Lin(Massachusetts General Hospital), Justin Buchanan(University of California San Diego), Sijia Chen(Brigham and Women's Hospital), Jian Shu(Broad Institute), Adam L. Haber(Broad Institute), Hattie Chung(Broad Institute), Daniel T. Montoro(Broad Institute), Taylor Adams(Yale University), Hananeh Aliee(Helmholtz Zentrum München), Jane Samuel(Broad Institute), Allon Zaneta Andrusivova(Science for Life Laboratory), Ilias Angelidis(Helmholtz Zentrum München), Orr Ashenberg(Broad Institute), Kevin Baßler(University of Bonn), Christophe Bécavin(Centre National de la Recherche Scientifique), Inbal Benhar(Broad Institute), Joseph Bergenstråhle(Science for Life Laboratory), Ludvig Bergenstråhle(Science for Life Laboratory), Liam Bolt(Wellcome Sanger Institute), Emelie Braun(Karolinska Institutet), Linh T. Bui(Translational Genomics Research Institute), Mark Chaffin(Broad Institute), Evgeny Chichelnitskiy(GTx (United States)), Joshua Chiou(University of California San Diego), Thomas M. Conlon(Helmholtz Zentrum München), Michael S. Cuoco(Broad Institute), Marie Deprez(Centre National de la Recherche Scientifique), David S. Fischer(Helmholtz Zentrum München), Astrid Gillich(Howard Hughes Medical Institute), Joshua Gould(Broad Institute), Minzhe Guo(Cincinnati Children's Hospital Medical Center), Austin J. Gutierrez(Translational Genomics Research Institute), Arun C. Habermann(Vanderbilt University Medical Center), Tyler Harvey(Broad Institute), Peng He(Wellcome Sanger Institute), Xiaomeng Hou(University of California San Diego), Lijuan Hu(Karolinska Institutet), Alok Jaiswal(Broad Institute), Peiyong Jiang(Chinese University of Hong Kong), Theodoros Kapellos(University of Bonn), Christin S. Kuo(Stanford Medicine), Ludvig Larsson(Science for Life Laboratory), Michael Leney-Greene(Broad Institute), Kyungtae Lim(University of Cambridge), Monika Litviňuková(Max Delbrück Center), Lu Ji(Chinese University of Hong Kong), Leif S. Ludwig(Broad Institute), Wendy Luo(Broad Institute), Henrike Maatz(Max Delbrück Center), Elo Madissoon(Wellcome Sanger Institute), Lira Mamanova(Wellcome Sanger Institute), Kasidet Manakongtreecheep(Broad Institute), Charles‐Hugo Marquette(Centre National de la Recherche Scientifique), Ian Mbano(Africa Health Research Institute), Alexi McAdams(Massachusetts Eye and Ear Infirmary), Ross J. Metzger(Stanford Medicine), Ahmad N. Nabhan(Howard Hughes Medical Institute), Sarah K. Nyquist(Broad Institute), Lolita Penland(Chan Zuckerberg Initiative (United States)), Olivier Poirion(University of California San Diego), Sergio Poli(Mount Sinai Medical Center), CanCan Qi(University Medical Center Groningen), Rachel Queen(Broad Institute), Daniel Reichart(Harvard University), Iván O. Rosas(Yale University), Jonas C. Schupp(Yale University), Rahul Sinha(Stanford University), Rene Sit(Chan Zuckerberg Initiative (United States)), Kamil Slowikowski(Broad Institute), Michal Slyper(Broad Institute), Neal Smith(Broad Institute), Alex Sountoulidis(Stockholm University), Maximilian Strunz(Helmholtz Zentrum München), Dawei Sun(University of Cambridge), Carlos Talavera‐López(Wellcome Sanger Institute), Peng Tan(Broad Institute), Jessica Tantivit(Broad Institute), Kyle J. Travaglini(Howard Hughes Medical Institute), Nathan R. Tucker(Broad Institute), Katherine Vernon(Broad Institute), Marc H. Wadsworth(Broad Institute), Julia Waldman(Broad Institute), Xiuting Wang(Icahn School of Medicine at Mount Sinai), Wenjun Yan(Harvard University), William Zhao(Icahn School of Medicine at Mount Sinai), Carly G.K. Ziegler(Broad Institute), The Human Cell Atlas Lung Biological Network
bioRxiv (Cold Spring Harbor Laboratory)
April 20, 2020
Cited by 268Open Access
Full Text

Abstract

ABSTRACT The COVID-19 pandemic, caused by the novel coronavirus SARS-CoV-2, creates an urgent need for identifying molecular mechanisms that mediate viral entry, propagation, and tissue pathology. Cell membrane bound angiotensin-converting enzyme 2 (ACE2) and associated proteases, transmembrane protease serine 2 (TMPRSS2) and Cathepsin L (CTSL), were previously identified as mediators of SARS-CoV2 cellular entry. Here, we assess the cell type-specific RNA expression of ACE2 , TMPRSS2 , and CTSL through an integrated analysis of 107 single-cell and single-nucleus RNA-Seq studies, including 22 lung and airways datasets (16 unpublished), and 85 datasets from other diverse organs. Joint expression of ACE2 and the accessory proteases identifies specific subsets of respiratory epithelial cells as putative targets of viral infection in the nasal passages, airways, and alveoli. Cells that co-express ACE2 and proteases are also identified in cells from other organs, some of which have been associated with COVID-19 transmission or pathology, including gut enterocytes, corneal epithelial cells, cardiomyocytes, heart pericytes, olfactory sustentacular cells, and renal epithelial cells. Performing the first meta-analyses of scRNA-seq studies, we analyzed 1,176,683 cells from 282 nasal, airway, and lung parenchyma samples from 164 donors spanning fetal, childhood, adult, and elderly age groups, associate increased levels of ACE2 , TMPRSS2 , and CTSL in specific cell types with increasing age, male gender, and smoking, all of which are epidemiologically linked to COVID-19 susceptibility and outcomes. Notably, there was a particularly low expression of ACE2 in the few young pediatric samples in the analysis. Further analysis reveals a gene expression program shared by ACE2 + TMPRSS2 + cells in nasal, lung and gut tissues, including genes that may mediate viral entry, subtend key immune functions, and mediate epithelial-macrophage cross-talk. Amongst these are IL6, its receptor and co-receptor, IL1R , TNF response pathways, and complement genes. Cell type specificity in the lung and airways and smoking effects were conserved in mice. Our analyses suggest that differences in the cell type-specific expression of mediators of SARS-CoV-2 viral entry may be responsible for aspects of COVID-19 epidemiology and clinical course, and point to putative molecular pathways involved in disease susceptibility and pathogenesis.


Related Papers